Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Journal of Oncology Practice|October 6, 2018
Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score-Matched Cohort StudyNicole Mittmann, Hasmik Beglaryan, Ning Liu, et al.
AIDS Care|March 5, 2015
Is any job better than no job? Labor market experiences and depressive symptoms in people living with HIVSergio Rueda, Peter Smith, Tsegaye Bekele, et al.
Plos One|February 1, 2020
Does early palliative identification improve the use of palliative care services?Nicole Mittmann, Ning Liu, Marnie MacKinnon, et al.
JAMA Dermatology|September 6, 2023
Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for MelanomaSarah B Bateni, Paul Nguyen, Antoine Eskander, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2021
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Qing Li, et al.
Radiology|December 5, 2018
Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter RegistryUr Metser, Anca Prica, David C Hodgson, et al.
Cancers|September 28, 2024
Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation ProjectSoo-Jin Seung, Nicole Mittmann, Zharmaine Ante, et al.
Journal of the National Cancer Institute|February 18, 2010
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancerPenelope A Bradbury, Dongsheng Tu, Lesley Seymour, et al.
AIDS and Behavior|September 30, 2010
Once daily dosing improves adherence to antiretroviral therapyJanet Raboud, Maggie Li, Sharon Walmsley, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical TrialAnca Prica, Annette E Hay, Michael Crump, et al.
Pageof 17